Abstract
Uncontrolled proliferation of endothelial cells is essential to the pathogenesis of pulmonary arterial hypertension (PAH). Both proliferation and cytoskeleton reorganization are associated with upregulation of the intermediate filament protein Nestin. Recently, accumulation of Nestin-expressing cells was found in pulmonary vascular lesions of PAH patients. The goal of this study is to determine if Nestin expression contributes to endothelial proliferation in pulmonary arterial hypertension, using both lung tissues and endothelial cells. Here we found that endothelial cells from complex and plexiform lesions of PAH patients expressed Nestin. These Nestin+ cells further stained positive for the angiogenic factors CXC chemokine ligand 12 and Wnt1. Likewise, in the chronic hypoxia/SU5416 animal model of pulmonary hypertension, Nestin+ endothelial cells were found in occlusive pulmonary vascular lesions. In vitro, both growing rat and human lung endothelial cells expressed Nestin protein. When Nestin was overexpressed in endothelial cells (both rat and human), Nestin overexpression promoted proliferation and expression of CXC chemokine ligand 12. Nestin overexpression further increased angiogenic tube formation in vitro. Conclusions: We found increased Nestin expression from endothelial cells of occlusive lung vascular lesions in severe pulmonary hypertension. Elevated Nestin expression likely contributes to unchecked pulmonary vascular proliferation and angiogenesis, possibly via induction of CXC chemokine ligand 12. Additional studies are required to determine whether targeting Nestin would be beneficial to treat PAH.
Highlights
Pulmonary arterial hypertension (PAH) is a devastating and deadly condition characterized by a progressive occlusive arteriopathy in the lung
Nestin+ cells resided in the pulmonary vascular lesions of patients with idiopathic PAH (Fig 1)
We identified a significant increase in the fraction of Wnt1+ Nestin+ cells in the muscular and non-muscular pulmonary arteries of idiopathic PAH (iPAH) patients, compared to muscular/non-muscular arteries of controls (Fig 2)
Summary
Pulmonary arterial hypertension (PAH) is a devastating and deadly condition characterized by a progressive occlusive arteriopathy in the lung. The extent of this remodeling in pulmonary arteries ranges from neointima formation and increased muscularization to complex plexiform lesions [1,2]. Patients with PAH have an improved prognosis due to pulmonary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have